Vaccine Current State & Logistics

Listen to a panel of experts discuss the vaccine logistics

In this episode, we’re highlighting a portion of HealthTrust’s COVID-19 Vaccine Current State & Hesitancy webinar focusing on logistics. If you’re looking for an in-depth discussion about COVID-19 vaccines, a behind the scenes look at distribution and an informed discussion on vaccine options, this is a conversation for you. We hope you find as much value in this Candid Conversation as we did.

1:06 – Second dose guidelines
2:45 – Logistics behind 1M in 8 weeks
4:14 – High-volume vaccine sites
6:14 – Impact on routine child immunizations
8:12 – Efficacy of single dose
10:55 – COVID variants explanation
13:10 – Proteins and antibodies
15:24 – National surveillance system
17:22 – Laboratory supply chain
18:20 – Public health labs and epidemics

Discussion Points:

Distribution phases
The importance of maintaining childhood vaccinations
Single dose vs multiple doses
COVID-19 variants

John Young, M.D., MBA, FACHE | Chief Medical Officer | HealthTrust

Jason Braithwaite, PharmD, MS, BCPS | Senior Director, Clinical Pharmacy Services | HealthTrust

Michelle D. Fiscus, M.D. FAAP | Medical Director | Vaccine-Preventable Diseases & Immunization Program | Tennessee Department of Health

Michael E. Nottidge, M.D., MPH, FACEP | Critical Care, TriStar Centennial Medical Center | HCA Healthcare

S. Shaefer Spires, M.D. | Assistant Professor of Medicine | Division of Infectious Diseases | Medical Director, DASON | Duke University School of Medicine